measuregroup/AID6172

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103200995_AID6172_PMID7608898_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103165719_AID6172_PMID7608898_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103170845_AID6172_PMID7608898_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103276082_AID6172_PMID7608898_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123090165_AID6172_PMID7608898_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70528
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103170845 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123090165 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103200995 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103276082 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103165719
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID6172

Total number of triples: 15.